nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Methotrexate—psoriatic arthritis	0.0979	0.113	CbGbCtD
Amprenavir—ABCB1—Methylprednisolone—psoriatic arthritis	0.0777	0.0901	CbGbCtD
Amprenavir—CYP2C19—Prednisone—psoriatic arthritis	0.0583	0.0676	CbGbCtD
Amprenavir—CYP2B6—Dexamethasone—psoriatic arthritis	0.0573	0.0665	CbGbCtD
Amprenavir—ABCB1—Betamethasone—psoriatic arthritis	0.0505	0.0586	CbGbCtD
Amprenavir—ABCB1—Prednisolone—psoriatic arthritis	0.0499	0.0578	CbGbCtD
Amprenavir—ABCB1—Prednisone—psoriatic arthritis	0.0471	0.0546	CbGbCtD
Amprenavir—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0466	0.054	CbGbCtD
Amprenavir—CYP3A5—Dexamethasone—psoriatic arthritis	0.0452	0.0524	CbGbCtD
Amprenavir—CYP2C8—Dexamethasone—psoriatic arthritis	0.0434	0.0503	CbGbCtD
Amprenavir—CYP2C19—Dexamethasone—psoriatic arthritis	0.0364	0.0422	CbGbCtD
Amprenavir—CYP3A4—Triamcinolone—psoriatic arthritis	0.0353	0.0409	CbGbCtD
Amprenavir—CYP2C9—Dexamethasone—psoriatic arthritis	0.0303	0.0351	CbGbCtD
Amprenavir—CYP3A4—Betamethasone—psoriatic arthritis	0.0303	0.0351	CbGbCtD
Amprenavir—CYP3A4—Prednisolone—psoriatic arthritis	0.0299	0.0346	CbGbCtD
Amprenavir—ABCB1—Dexamethasone—psoriatic arthritis	0.0294	0.0341	CbGbCtD
Amprenavir—CYP3A4—Prednisone—psoriatic arthritis	0.0282	0.0327	CbGbCtD
Amprenavir—CYP2D6—Dexamethasone—psoriatic arthritis	0.0277	0.0321	CbGbCtD
Amprenavir—ABCB1—Methotrexate—psoriatic arthritis	0.0236	0.0274	CbGbCtD
Amprenavir—CYP3A4—Dexamethasone—psoriatic arthritis	0.0176	0.0204	CbGbCtD
Amprenavir—Affective disorder—Methylprednisolone—psoriatic arthritis	0.0105	0.0762	CcSEcCtD
Amprenavir—Loose stools—Auranofin—psoriatic arthritis	0.00811	0.059	CcSEcCtD
Amprenavir—Buffalo hump—Prednisone—psoriatic arthritis	0.00519	0.0377	CcSEcCtD
Amprenavir—Lipohypertrophy—Prednisone—psoriatic arthritis	0.00477	0.0347	CcSEcCtD
Amprenavir—Opportunistic infection—Methylprednisolone—psoriatic arthritis	0.00326	0.0237	CcSEcCtD
Amprenavir—Opportunistic infection—Betamethasone—psoriatic arthritis	0.00297	0.0216	CcSEcCtD
Amprenavir—Opportunistic infection—Dexamethasone—psoriatic arthritis	0.00297	0.0216	CcSEcCtD
Amprenavir—Neutropenia—Auranofin—psoriatic arthritis	0.00264	0.0192	CcSEcCtD
Amprenavir—Opportunistic infection—Prednisone—psoriatic arthritis	0.00258	0.0188	CcSEcCtD
Amprenavir—Opportunistic infection—Methotrexate—psoriatic arthritis	0.00216	0.0157	CcSEcCtD
Amprenavir—Flatulence—Auranofin—psoriatic arthritis	0.00194	0.0141	CcSEcCtD
Amprenavir—Hypertriglyceridaemia—Prednisone—psoriatic arthritis	0.00181	0.0132	CcSEcCtD
Amprenavir—Angioedema—Auranofin—psoriatic arthritis	0.00179	0.0131	CcSEcCtD
Amprenavir—Blood triglycerides increased—Prednisone—psoriatic arthritis	0.00159	0.0116	CcSEcCtD
Amprenavir—Anorexia—Auranofin—psoriatic arthritis	0.00153	0.0111	CcSEcCtD
Amprenavir—Decreased appetite—Auranofin—psoriatic arthritis	0.00139	0.0101	CcSEcCtD
Amprenavir—Inflammation—Methylprednisolone—psoriatic arthritis	0.00135	0.00985	CcSEcCtD
Amprenavir—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00131	0.00953	CcSEcCtD
Amprenavir—Abdominal pain—Auranofin—psoriatic arthritis	0.00127	0.00921	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.0012	0.00869	CcSEcCtD
Amprenavir—Pruritus—Auranofin—psoriatic arthritis	0.00113	0.00825	CcSEcCtD
Amprenavir—Hypercholesterolaemia—Prednisone—psoriatic arthritis	0.0011	0.008	CcSEcCtD
Amprenavir—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.0011	0.008	CcSEcCtD
Amprenavir—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.0011	0.00798	CcSEcCtD
Amprenavir—Diarrhoea—Auranofin—psoriatic arthritis	0.0011	0.00798	CcSEcCtD
Amprenavir—Vomiting—Auranofin—psoriatic arthritis	0.00102	0.00741	CcSEcCtD
Amprenavir—Rash—Auranofin—psoriatic arthritis	0.00101	0.00735	CcSEcCtD
Amprenavir—Dermatitis—Auranofin—psoriatic arthritis	0.00101	0.00734	CcSEcCtD
Amprenavir—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.000997	0.00725	CcSEcCtD
Amprenavir—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.000997	0.00725	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—psoriatic arthritis	0.000957	0.00696	CcSEcCtD
Amprenavir—Nausea—Auranofin—psoriatic arthritis	0.000952	0.00692	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—psoriatic arthritis	0.000897	0.00652	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisone—psoriatic arthritis	0.000869	0.00632	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000841	0.00612	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00079	0.00574	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000785	0.00571	CcSEcCtD
Amprenavir—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000726	0.00528	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.000726	0.00528	CcSEcCtD
Amprenavir—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000725	0.00527	CcSEcCtD
Amprenavir—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000722	0.00525	CcSEcCtD
Amprenavir—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000721	0.00524	CcSEcCtD
Amprenavir—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000676	0.00492	CcSEcCtD
Amprenavir—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000676	0.00492	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000666	0.00485	CcSEcCtD
Amprenavir—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000659	0.00479	CcSEcCtD
Amprenavir—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000659	0.00479	CcSEcCtD
Amprenavir—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000655	0.00477	CcSEcCtD
Amprenavir—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000655	0.00477	CcSEcCtD
Amprenavir—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000649	0.00472	CcSEcCtD
Amprenavir—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000613	0.00445	CcSEcCtD
Amprenavir—Neutropenia—Prednisone—psoriatic arthritis	0.000611	0.00444	CcSEcCtD
Amprenavir—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000589	0.00428	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000583	0.00424	CcSEcCtD
Amprenavir—Depression—Prednisone—psoriatic arthritis	0.000581	0.00422	CcSEcCtD
Amprenavir—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000578	0.00421	CcSEcCtD
Amprenavir—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000575	0.00418	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000574	0.00417	CcSEcCtD
Amprenavir—Angioedema—Prednisolone—psoriatic arthritis	0.000572	0.00416	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisone—psoriatic arthritis	0.000571	0.00415	CcSEcCtD
Amprenavir—Discomfort—Prednisolone—psoriatic arthritis	0.000527	0.00383	CcSEcCtD
Amprenavir—Angioedema—Triamcinolone—psoriatic arthritis	0.000526	0.00383	CcSEcCtD
Amprenavir—Angioedema—Methylprednisolone—psoriatic arthritis	0.000525	0.00382	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000523	0.00381	CcSEcCtD
Amprenavir—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000514	0.00374	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—psoriatic arthritis	0.00051	0.00371	CcSEcCtD
Amprenavir—Myalgia—Triamcinolone—psoriatic arthritis	0.00049	0.00357	CcSEcCtD
Amprenavir—Myalgia—Methylprednisolone—psoriatic arthritis	0.000489	0.00356	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000486	0.00353	CcSEcCtD
Amprenavir—Depression—Methotrexate—psoriatic arthritis	0.000485	0.00353	CcSEcCtD
Amprenavir—Discomfort—Triamcinolone—psoriatic arthritis	0.000484	0.00352	CcSEcCtD
Amprenavir—Discomfort—Methylprednisolone—psoriatic arthritis	0.000483	0.00351	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000482	0.00351	CcSEcCtD
Amprenavir—Angioedema—Betamethasone—psoriatic arthritis	0.000477	0.00347	CcSEcCtD
Amprenavir—Angioedema—Dexamethasone—psoriatic arthritis	0.000477	0.00347	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00046	0.00335	CcSEcCtD
Amprenavir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00046	0.00334	CcSEcCtD
Amprenavir—Paraesthesia—Prednisolone—psoriatic arthritis	0.000459	0.00334	CcSEcCtD
Amprenavir—Mental disorder—Prednisone—psoriatic arthritis	0.000458	0.00333	CcSEcCtD
Amprenavir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000455	0.00331	CcSEcCtD
Amprenavir—Malnutrition—Prednisone—psoriatic arthritis	0.000455	0.00331	CcSEcCtD
Amprenavir—Myalgia—Dexamethasone—psoriatic arthritis	0.000445	0.00324	CcSEcCtD
Amprenavir—Myalgia—Betamethasone—psoriatic arthritis	0.000445	0.00324	CcSEcCtD
Amprenavir—Discomfort—Dexamethasone—psoriatic arthritis	0.000439	0.0032	CcSEcCtD
Amprenavir—Discomfort—Betamethasone—psoriatic arthritis	0.000439	0.0032	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000428	0.00311	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000427	0.00311	CcSEcCtD
Amprenavir—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000422	0.00307	CcSEcCtD
Amprenavir—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000421	0.00306	CcSEcCtD
Amprenavir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000418	0.00304	CcSEcCtD
Amprenavir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000418	0.00304	CcSEcCtD
Amprenavir—Angioedema—Prednisone—psoriatic arthritis	0.000416	0.00302	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000413	0.003	CcSEcCtD
Amprenavir—Anorexia—Dexamethasone—psoriatic arthritis	0.000406	0.00296	CcSEcCtD
Amprenavir—Anorexia—Betamethasone—psoriatic arthritis	0.000406	0.00296	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000405	0.00295	CcSEcCtD
Amprenavir—Fatigue—Triamcinolone—psoriatic arthritis	0.000405	0.00295	CcSEcCtD
Amprenavir—Fatigue—Methylprednisolone—psoriatic arthritis	0.000404	0.00294	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000388	0.00283	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000388	0.00283	CcSEcCtD
Amprenavir—Myalgia—Prednisone—psoriatic arthritis	0.000387	0.00282	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000385	0.0028	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000383	0.00279	CcSEcCtD
Amprenavir—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000383	0.00278	CcSEcCtD
Amprenavir—Paraesthesia—Betamethasone—psoriatic arthritis	0.000383	0.00278	CcSEcCtD
Amprenavir—Discomfort—Prednisone—psoriatic arthritis	0.000383	0.00278	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—psoriatic arthritis	0.000383	0.00278	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—psoriatic arthritis	0.00038	0.00277	CcSEcCtD
Amprenavir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000371	0.0027	CcSEcCtD
Amprenavir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000371	0.0027	CcSEcCtD
Amprenavir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000371	0.0027	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000368	0.00268	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000368	0.00268	CcSEcCtD
Amprenavir—Fatigue—Dexamethasone—psoriatic arthritis	0.000368	0.00267	CcSEcCtD
Amprenavir—Fatigue—Betamethasone—psoriatic arthritis	0.000368	0.00267	CcSEcCtD
Amprenavir—Nervous system disorder—Prednisone—psoriatic arthritis	0.000364	0.00265	CcSEcCtD
Amprenavir—Skin disorder—Prednisone—psoriatic arthritis	0.000361	0.00262	CcSEcCtD
Amprenavir—Anorexia—Prednisone—psoriatic arthritis	0.000354	0.00257	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000349	0.00254	CcSEcCtD
Amprenavir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000349	0.00254	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000338	0.00246	CcSEcCtD
Amprenavir—Asthenia—Triamcinolone—psoriatic arthritis	0.000337	0.00245	CcSEcCtD
Amprenavir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000337	0.00245	CcSEcCtD
Amprenavir—Abdominal pain—Betamethasone—psoriatic arthritis	0.000337	0.00245	CcSEcCtD
Amprenavir—Asthenia—Methylprednisolone—psoriatic arthritis	0.000336	0.00245	CcSEcCtD
Amprenavir—Paraesthesia—Prednisone—psoriatic arthritis	0.000333	0.00243	CcSEcCtD
Amprenavir—Pruritus—Triamcinolone—psoriatic arthritis	0.000332	0.00242	CcSEcCtD
Amprenavir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000332	0.00241	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—psoriatic arthritis	0.000324	0.00235	CcSEcCtD
Amprenavir—Decreased appetite—Prednisone—psoriatic arthritis	0.000323	0.00235	CcSEcCtD
Amprenavir—Rash—Prednisolone—psoriatic arthritis	0.000322	0.00234	CcSEcCtD
Amprenavir—Dermatitis—Prednisolone—psoriatic arthritis	0.000322	0.00234	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000322	0.00234	CcSEcCtD
Amprenavir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000321	0.00233	CcSEcCtD
Amprenavir—Fatigue—Prednisone—psoriatic arthritis	0.00032	0.00233	CcSEcCtD
Amprenavir—Headache—Prednisolone—psoriatic arthritis	0.00032	0.00233	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—psoriatic arthritis	0.00032	0.00233	CcSEcCtD
Amprenavir—Asthenia—Betamethasone—psoriatic arthritis	0.000306	0.00223	CcSEcCtD
Amprenavir—Asthenia—Dexamethasone—psoriatic arthritis	0.000306	0.00223	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000304	0.00221	CcSEcCtD
Amprenavir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000304	0.00221	CcSEcCtD
Amprenavir—Nausea—Prednisolone—psoriatic arthritis	0.000304	0.00221	CcSEcCtD
Amprenavir—Pruritus—Dexamethasone—psoriatic arthritis	0.000302	0.00219	CcSEcCtD
Amprenavir—Pruritus—Betamethasone—psoriatic arthritis	0.000302	0.00219	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—psoriatic arthritis	0.000301	0.00219	CcSEcCtD
Amprenavir—Vomiting—Triamcinolone—psoriatic arthritis	0.000299	0.00217	CcSEcCtD
Amprenavir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000298	0.00217	CcSEcCtD
Amprenavir—Rash—Triamcinolone—psoriatic arthritis	0.000296	0.00216	CcSEcCtD
Amprenavir—Dermatitis—Triamcinolone—psoriatic arthritis	0.000296	0.00215	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—psoriatic arthritis	0.000296	0.00215	CcSEcCtD
Amprenavir—Rash—Methylprednisolone—psoriatic arthritis	0.000296	0.00215	CcSEcCtD
Amprenavir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000295	0.00215	CcSEcCtD
Amprenavir—Headache—Triamcinolone—psoriatic arthritis	0.000294	0.00214	CcSEcCtD
Amprenavir—Headache—Methylprednisolone—psoriatic arthritis	0.000294	0.00214	CcSEcCtD
Amprenavir—Abdominal pain—Prednisone—psoriatic arthritis	0.000294	0.00214	CcSEcCtD
Amprenavir—Diarrhoea—Betamethasone—psoriatic arthritis	0.000292	0.00212	CcSEcCtD
Amprenavir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000292	0.00212	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000283	0.00206	CcSEcCtD
Amprenavir—Nausea—Triamcinolone—psoriatic arthritis	0.000279	0.00203	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—psoriatic arthritis	0.000279	0.00203	CcSEcCtD
Amprenavir—Nausea—Methylprednisolone—psoriatic arthritis	0.000279	0.00203	CcSEcCtD
Amprenavir—Vomiting—Dexamethasone—psoriatic arthritis	0.000271	0.00197	CcSEcCtD
Amprenavir—Vomiting—Betamethasone—psoriatic arthritis	0.000271	0.00197	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—psoriatic arthritis	0.00027	0.00196	CcSEcCtD
Amprenavir—Rash—Dexamethasone—psoriatic arthritis	0.000269	0.00196	CcSEcCtD
Amprenavir—Rash—Betamethasone—psoriatic arthritis	0.000269	0.00196	CcSEcCtD
Amprenavir—Dermatitis—Betamethasone—psoriatic arthritis	0.000269	0.00195	CcSEcCtD
Amprenavir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000269	0.00195	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000268	0.00195	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—psoriatic arthritis	0.000268	0.00195	CcSEcCtD
Amprenavir—Headache—Dexamethasone—psoriatic arthritis	0.000267	0.00194	CcSEcCtD
Amprenavir—Headache—Betamethasone—psoriatic arthritis	0.000267	0.00194	CcSEcCtD
Amprenavir—Asthenia—Prednisone—psoriatic arthritis	0.000266	0.00194	CcSEcCtD
Amprenavir—Pruritus—Prednisone—psoriatic arthritis	0.000263	0.00191	CcSEcCtD
Amprenavir—Diarrhoea—Prednisone—psoriatic arthritis	0.000254	0.00185	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000254	0.00185	CcSEcCtD
Amprenavir—Nausea—Betamethasone—psoriatic arthritis	0.000253	0.00184	CcSEcCtD
Amprenavir—Nausea—Dexamethasone—psoriatic arthritis	0.000253	0.00184	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000245	0.00178	CcSEcCtD
Amprenavir—Vomiting—Prednisone—psoriatic arthritis	0.000236	0.00172	CcSEcCtD
Amprenavir—Rash—Prednisone—psoriatic arthritis	0.000234	0.0017	CcSEcCtD
Amprenavir—Dermatitis—Prednisone—psoriatic arthritis	0.000234	0.0017	CcSEcCtD
Amprenavir—Headache—Prednisone—psoriatic arthritis	0.000233	0.00169	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—psoriatic arthritis	0.000223	0.00162	CcSEcCtD
Amprenavir—Nausea—Prednisone—psoriatic arthritis	0.000221	0.0016	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—psoriatic arthritis	0.00022	0.0016	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000212	0.00154	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—psoriatic arthritis	0.000197	0.00144	CcSEcCtD
Amprenavir—Rash—Methotrexate—psoriatic arthritis	0.000196	0.00142	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—psoriatic arthritis	0.000195	0.00142	CcSEcCtD
Amprenavir—Headache—Methotrexate—psoriatic arthritis	0.000194	0.00141	CcSEcCtD
Amprenavir—Nausea—Methotrexate—psoriatic arthritis	0.000184	0.00134	CcSEcCtD
